Sahin, Ibrahim EthemAlpay, MerveSonmez, Cemil Isik2021-12-012021-12-0120200393-63842283-9720https://doi.org/10.19193/0393-6384_2020_2_130https://hdl.handle.net/20.500.12684/10799Introduction: Vitamin D deficiency and obesity are common controversial health problems. Vit D supports lipolysiv from the outside, stimulates lipogenesis. Perilipine protein, which allows the use of lipids in the mitochondria in cell. Our main aim of this research was to control obesity prognosis monitoring Perilipine levels related by WO treatments. Methods: During winter months, patients that have admitted the hospital whose ages ranged from 18 to 65 years at 80 obese and normal BMI individuals were included the study. Blood samples from patients were taken and measured for VitD level. Experimental groups arranged again according to BMI and VitD results. Results: The mean age of the patients was +/- 34(18-65). After organized samples, vitamin D deficiency group which 25-OH D levels were < 20 nglml, were 37.75 +/- 4.79 higher Perilipine levels than normal VItD individuals. However, Perilipine levels were increased in obese patients display positive correlation with BMI. Discussion: These results were indicated that high frequency of vitamin D deficiency drives obesity relatively especially in winter months. The research findings suggest that Perilipine expression has direct correlation by vitamin D alteration. For this purpose, Perilipine can be a novel marker to prevent obesity and should he controlled previously identified obesity groups treated new methods of VitD uptake.en10.19193/0393-6384_2020_2_130info:eu-repo/semantics/closedAccessPerilipineObesityVitamin D levelBMIadipokinesHormone-Sensitive LipaseA-Mediated LipolysisBody-Mass IndexD DeficiencyAdipocyte LipolysisDroplet ProteinsFamilyMouseFatObesityArticle3628358422-s2.0-85083392932WOS:000526121600015N/AQ4